✦ LIBER ✦

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

✍ Scribed by Kenny, L. M.

Book ID: 121359360
Publisher: The Society of Nuclear Medicine
Year: 2013
Tongue: English
Weight: 51 KB
Volume: 54
Category: Article
ISSN: 0161-5505
DOI: 10.2967/jnumed.113.126342

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

18F-FDG PET/CT for Early Prediction of R

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

✍ Gebhart, G.; Gamez, C.; Holmes, E.; Robles, J.; Garcia, C.; Cortes, M.; de Azamb 📂 Article 📅 2013 🏛 The Society of Nuclear Medicine 🌐 English ⚖ 330 KB

5013 ORAL FDG-PET/CT for Early Predictio

5013 ORAL FDG-PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-positive Breast Cancer Patients: the Neo-ALTTO Study Results

✍ Gamez, C.; Flamen, P.; Holmes, E.; Robles, J.; Gebhart, G.; Di Cosimo, S.; Eidtm 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 59 KB

HER2-positive breast cancer:18F-FDG PET

HER2-positive breast cancer:18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy

✍ Humbert, Olivier; Cochet, Alexandre; Riedinger, Jean-Marc; Berriolo-Riedinger, A 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 359 KB